Ascend Wellness Holdings (AAWH) Net Cash Flow (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Net Cash Flow of -$24.8 million for Q1 2026, down 310.15% year-over-year from $11.8 million in Q1 2025, and down 1451.13% quarter-over-quarter from -$1.6 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Net Cash Flow (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$24.8 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 310.15% year-over-year to -$24.8 million; the TTM figure through Mar 2026 stood at -$39.1 million (down 244.17% YoY), while the FY2025 annual figure was -$2.6 million, down 116.37% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$24.8 million, down from -$1.6 million in the prior quarter.
- The five-year high for Net Cash Flow was $23.0 million in Q4 2024, with the low at -$49.2 million in Q3 2022.
- The 5-year median for Net Cash Flow is -$4.1 million (2023), against an average of -$5.6 million.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow tumbled 346.88% in 2024, then jumped 2874.75% in 2025.
- Ascend Wellness Holdings' Net Cash Flow stood at -$17.2 million in 2022, then jumped by 149.79% to $8.6 million in 2023, then soared by 167.56% to $23.0 million in 2024, then tumbled by 106.95% to -$1.6 million in 2025, then slumped by 1451.13% to -$24.8 million in 2026.
- Business Quant data shows AAWH's Net Cash Flow at -$24.8 million in Q1 2026, -$1.6 million in Q4 2025, and -$8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | 6.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.08 Mn |
| Jun 30, 2026 | 6.08 Mn |
| Mar 31, 2026 | -24.76 Mn |
| Mar 31, 2026 | -24.76 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Jun 30, 2025 | -4.76 Mn |
| Jun 30, 2025 | -4.76 Mn |
| Mar 31, 2025 | 11.78 Mn |
| Mar 31, 2025 | 11.78 Mn |
| Dec 31, 2024 | 22.98 Mn |
| Dec 31, 2024 | 22.98 Mn |
| Sep 30, 2024 | -18.43 Mn |
| Sep 30, 2024 | -18.43 Mn |
| Jun 30, 2024 | 10.81 Mn |
| Jun 30, 2024 | 10.81 Mn |
| Mar 31, 2024 | 396,000.00 |
| Mar 31, 2024 | 396,000.00 |